Endometrial Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”

Slides:



Advertisements
Similar presentations
Gynecologic Oncology Group Gynecologic Oncology Group Uterine Corpus Trials: GCIG David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. Director and Dallas Foundation.
Advertisements

Management of Endometrial Cancer dr Zohreh Yousefi / Fellowship of Gynecology Oncology Ghaem Hospital, Mashhad University of Medical Sciences.
Cancer Survivorship Endometrial Cancer Module Part 2 Start Case ©2007. David Geffen School of Medicine, UCLA.
Staging for Cervical Cancer Can be done under anaesthesia WHO recommends downstaging Aim is to obtain adequate Histological specimen for conformation (
Age-standardized incidence of cervical cancer in selected worldwide countries Zimbabwe, Harare Peru, Trujilo India, Madras Colombia, Cali Argentina India,
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
The Dept. OB/GY of the first hospital of Xi’an Jiao Tong university The Dept. OB/GY of the first hospital of Xi’an Jiao Tong university Cervical carcinoma.
Endometrial Cancer Tseng Jen-Yu 02/05/2007 Tseng Jen-Yu 02/05/2007.
Endometrial carcinoma
Tim Broadhead Consultant Gynaecologist & Gynaecological Oncologist
CARCINOMA OF THE UTERINE CERVIX BY: DR
Cervical Cancer Keith Unger 2/24/06. Clinical History 47 yo F with vaginal bleeding and pelvic pain On exam, large cervical mass with parametrial involvement.
Special Tutorial Programme Professor Deirdre J Murphy Trinity College.
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
Impact of imaging on newer radiation techniques in Gynaecological cancer.
A surgical approach to uterine cancer in a single institution August July 2014 M. McCarthy (Medical Student) & M. Hewitt Cork University Maternity.
District 1 ACOG Medical Student Teaching Module 2009
Carcinoma of the Endometrium1 CARCINOMA OF THE ENDOMETRIUM Wen Di, M.D. , Ph.D.
Xi-Shi Liu Obstetrics and Gynecology Hospital Fudan university
Malignant Disease Of The Uterus Dr Khalid Sait FRCSC A.Professor of Gynecological Oncology KAAUH, Jeddah( KSA)
Cervical Cancer By: Kajal Haghmoradi.
CARCINOMA OF THE ENDOMETRIUM
Evidence Based Decision Making In Gynecologic Cancer Paolo Zola Turin, ITALY Adriana Bermudez Buenos Aires, ARGENTINA.
Endometrial Cancer ASSOCIATE PROFESSOR Iolanda Blidaru MD, PhD.
Gynaecologische Tumoren: Internationale richtlijnen en Nieuwe perspectieven in diagnostiek en behandeling SYMPOSIUM ONCOLOGIE – 7 JUNI 2008 Philippe Van.
Cancer of the Vulva. Essentials of Diagnosis Typically occurs in postmenopausal women. Long history of vulvar irritation with pruritus, local discomfort,
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.

Ovarian Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
CET Cancer Center Oakland California High Dose Rate (HDR) Brachytherapy Gynecological Cancer D. Jeffrey Demanes M.D
Optimal Surgery for Ovarian and Endometrial Cancers Jason Dodge, MD, FRCSC, MEd May 11 th, 2012.
Management of Endometrial Cancer in 2008 Marcus E. Randall, MD, FACR Chair and Professor Markey Foundation Endowed Chair Department of Radiation Medicine.
Endometrial Carcinoma
Are there benefits from chemotherapy to early endometrial cancer
Radiation Therapy in the Management of Cervical Carcinoma Patrick S Swift, MD Medical Director, Radiation Oncology Alta Bates Comprehensive Cancer Center.
TEMPLATE DESIGN © ONCOLOGICAL REFERRAL PATTERNS OF GYNAECOLOGICAL CANCER PATIENTS OVER 2010 – 2011 THE NEED FOR GYNAECOLOGIC.
TEMPLATE DESIGN © Endometrial large cell neuroendocrine carcinoma : a case report Reina Sato, Aiko Kawano, Hiroyuki Shigeta.
THE OUTBACK TRIAL A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared.
17 th century microscopes In The Name of God PARISA REZAEI,M.D.,AP.CP.
Adjuvant High-Dose-Rate Brachytherapy Alone for Stage I/II Endometrial Adenocarcinoma using a 4-Gray versus 6-Gray Fractionation Scheme Marie Lynn Racine,
Endometrial Committee David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. Director and Dallas Foundation Chair in Gynecologic Oncology Professor of Obstetrics.
REVISED FIGO STAGING SYSTEMS FOR GYNAECOLOGICAL CANCERS (2009) Glenn McCluggage, Belfast Trust.
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Adjuvant treatment for endometrial cancer Ameri A Associate Professor of Radiation Oncology Shahid Beheshti University of Medical Sciences Dec Pars.
Invasive cervical cancer. Background Most common cancer of women in Africa, most common gynaecologic cancer, most common cancer of black and coloured.
KARIMA SALAMA ENDOMETRIAL CANCER. Epidemiology Most common gynecological cancer in the developed countries, with an incidence of 12.9 per 100,000 women.
ENDOMETRIAL CARCINOMA UPDATES Dr Marco Matos Gold Coast Cancer Care, Gold Coast University Hospital and Pacific Private Oncology Group.
Treatment for Cervical Cancer
PURPOSE PURPOSE METHODSMETHODS CONCLUSIONSCONCLUSIONS Long-term results of daily HDR brachytherapy in the postoperative setting of endometrial carcinoma.
What’s New in Endometrial Cancer Henry Kitchener April 2009.
Malignant disease of the body of the uterus
Malignant disease of the body of the uterus
Postmenopausal bleeding
Dose dense chemotherapy in the adjuvant treatment of ovarian cancer
Benign and Malignant cysts and tumors of the ovary
THREE OR FOUR FRACTIONS PER WEEK IN POSTOPERATIVE HIGH DOSE RATE BRACHYTHERAPY (HDRBT) FOR ENDOMETRIAL CARCINOMA (EC). Rovirosa A1, Vargas M1, Ascaso C2,
Overzicht activiteiten werkgroep medicamenteuze therapie
Amant F – Gynecological Oncology - UZ Gasthuisberg, Leuven
Comparative Results of Vaginal Relapses and Toxicity of Three 192-Ir HDR brachytherapy (BT) Schedules in Postoperative Endometrial Carcinoma (EC). Rovirosa.
Concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after chemoradiation: outcome and survival S.T. Heijkoop1,2; H.C. van.
Malignant disease of the body of the uterus
Prof. Shaila Anwar Professor Obs & Gynae
Uterine cancer Uterine mesenchymal neoplasms
Management of endometrial cancer found on routine hysterectomy for benign disease Prof Dr M Anıl Onan MAY ANTALYA.
ENDOMETRIAL CARCINOMA
Fallopian Tube Cancer Paweł Sadłecki
Airedale NHS Foundation Trust
Jamie E. Chaft, MD, Camelia S. Sima, MD, MS, Michelle S
Presentation transcript:

Endometrial Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”

Question 1 A 64 year old women presented to her GP with an episode of post- menopausal bleeding. She was referred to a surgical gynaecological oncologist who performed a hysteroscopy and biopsy. What is the most likely diagnosis? Click Here For Answer Large cell, non-keratinizing squamous cell carcinoma of the cervix Adenocarcinoma of the cervix Endometrioid carcinoma of the endometrium Serous carcinoma of the endometrium Clear cell carcinoma of the endometrium

Question 1 A 64 year old women presented to her GP with an episode of post- menopausal bleeding. She was referred to a surgical gynaecological oncologist who performed a hysteroscopy and biopsy. What is the most likely diagnosis? Click Here For Next Question Large cell, non-keratinizing squamous cell carcinoma of the cervix Adenocarcinoma of the cervix Endometrioid carcinoma of the endometrium Serous carcinoma of the endometrium Clear cell carcinoma of the endometrium

Question 2 A 50 year old women underwent a TAH, BSO and bilateral pelvic lymphadenectomy for endometrial cancer. On histological review she was found to have a grade 2 endometrial adenocarcinoma invading into the outer half of the myometrium. A few cervical glands were involved and there were also small deposits in the omentum. What stage is her disease? Click Here For Answer Stage IV Stage IIB Stage IIIA Stage IIIB Stage IIIC

Question 2 A 50 year old women underwent a TAH, BSO and bilateral pelvic lymphadenectomy for endometrial cancer. On histological review she was found to have a grade 2 endometrial adenocarcinoma invading into the outer half of the myometrium. A few cervical glands were involved and there were also small deposits in the omentum. What stage is her disease? Click Here For Next Question Stage IV Stage IIB Stage IIIA Stage IIIB Stage IIIC

Question 3 A 35 year old women was diagnosed with a stage IIB endometrial carcinoma and underwent a TAH, BSO and bilateral pelvic lymphadenectomy. What is the most appropriate adjuvant treatment? Click Here For Answer No adjuvant treatment Vaginal brachytherapy only Pelvic EBRT only Pelvic EBRT and vaginal brachytherapy Chemotherapy followed by pelvic EBRT and vaginal brachytherapy

Question 3 A 35 year old women was diagnosed with a stage IIB endometrial carcinoma and underwent a TAH, BSO and bilateral pelvic lymphadenectomy. What is the most appropriate adjuvant treatment? Click Here For Next Question No adjuvant treatment Vaginal brachytherapy only Pelvic EBRT only Pelvic EBRT and vaginal brachytherapy Chemotherapy followed by pelvic EBRT and vaginal brachytherapy

Question 4 A 42 year old woman underwent a TAH, BSO and bilateral pelvic lymphadenectomy and was found to have stage IIIC endometrial adenocarcinoma. She is offered adjuvant chemotherapy. Which drug or drug-combination is most likely to cause peripheral neuropathy? Click Here For Answer Cisplatin / paclitaxel Single-agent carboplatin Carboplatin / paclitaxel Carboplatin / docetaxel Cisplatin / docetaxel

Question 4 A 42 year old woman underwent a TAH, BSO and bilateral pelvic lymphadenectomy and was found to have stage IIIC endometrial adenocarcinoma. She is offered adjuvant chemotherapy. Which drug or drug-combination is most likely to cause peripheral neuropathy? Click Here For Next question Cisplatin / paclitaxel Single-agent carboplatin Carboplatin / paclitaxel Carboplatin / docetaxel Cisplatin / docetaxel

Question 5 A 48 year old woman is offered chemotherapy for stage IV endometrial cancer. Which drug combination is most active in endometrial carcinoma? Click Here For Answer Doxorubicin / carboplatin Doxorubicin / cisplatin Doxorubicin / paclitaxel / cisplatin Paclitaxel / cisplatin Doxorubicin / carboplatin / paclitaxel

Question 5 A 48 year old woman is offered chemotherapy for stage IV endometrial cancer. Which drug combination is most active in endometrial carcinoma? Click Here For Next Question Doxorubicin / carboplatin Doxorubicin / cisplatin Doxorubicin / paclitaxel / cisplatin Paclitaxel / cisplatin Doxorubicin / carboplatin / paclitaxel

Question 6 A 63 year old woman is offered radiotherapy as part of the ASTEC study. Which of the following FIGO stages, if any, is suitable for entry into the trial? Click Here For Answer Stage IB G2 Stage IC G2 Stage IIA G2 Stage IIB G2 None of the above

Question 6 A 63 year old woman is offered radiotherapy as part of the ASTEC study. Which of the following FIGO stages, if any, is suitable for entry into the trial? Click Here For Next Question Stage IB G2 Stage IC G2 Stage IIA G2 Stage IIB G2 None of the above

Question 7 A 67 year old woman is offered adjuvant EBRT and brachytherapy treatment for stage II endometrial carcinoma. Which is the most suitable dose? Click Here For Answer 45Gy in 25# EBRT + 15Gy LDR brachytherapy to 0.5cm 45Gy in 25# EBRT + 20Gy LDR brachytherapy to 0.5cm 45Gy in 25# EBRT + 25Gy LDR brachytherapy to 0.5cm 50.4Gy in 28# EBRT + 15Gy LDR brachytherapy to 0.5cm 50.4Gy in 28# EBRT + 20Gy LDR brachytherapy to 0.5cm

Question 7 A 67 year old woman is offered adjuvant EBRT and brachytherapy treatment for stage II endometrial carcinoma. Which is the most suitable dose? Click Here For Next Question 45Gy in 25# EBRT + 15Gy LDR brachytherapy to 0.5cm 45Gy in 25# EBRT + 20Gy LDR brachytherapy to 0.5cm 45Gy in 25# EBRT + 25Gy LDR brachytherapy to 0.5cm 50.4Gy in 28# EBRT + 15Gy LDR brachytherapy to 0.5cm 50.4Gy in 28# EBRT + 20Gy LDR brachytherapy to 0.5cm

Question 8 A 45 year old woman has a diagnosis of serous carcinoma of the endometrium on biopsy. A surgical gynaecological oncologist operates. What is the most suitable operation? Click Here For Answer TAH & BSO only TAH & BSO & bilateral pelvic lymphadenectomy (BPL) TAH & BSO & omentectomy TAH & BSO & BPL & omentectomy Staging laparotomy

Question 8 A 45 year old woman has a diagnosis of serous carcinoma of the endometrium on biopsy. A surgical gynaecological oncologist operates. What is the most suitable operation? Click Here For Next Question TAH & BSO only TAH & BSO & bilateral pelvic lymphadenectomy (BPL) TAH & BSO & omentectomy TAH & BSO & BPL & omentectomy Staging laparotomy

Question 9 A 43 year old woman has a diagnosis of stage IIIA serous carcinoma of the endometrium. What is the most suitable adjuvant treatment? Click Here For Answer No adjuvant treatment Radiotherapy only Chemotherapy only Chemotherapy then radiotherapy Radiotherapy then chemotherapy

Question 9 A 43 year old woman has a diagnosis of stage IIIA serous carcinoma of the endometrium. What is the most suitable adjuvant treatment? Click Here For Next Slide No adjuvant treatment Radiotherapy only Chemotherapy only Chemotherapy then radiotherapy Radiotherapy then chemotherapy

The End